Anxiety and depression are often reported among women with BRCA1/2 mutations, most commonly among those who are undergoing genetic testing19, undergoing prophylactic surgeries24, and/or during biannual surveillance appointments30. Here, BRCA1 is linked to depressive symptom measurement.